Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $1.243B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 2,278,203 | $154M | 12.4% | $19.93 | +272.0% | Common | 834203309 |
| — | Verona Pharma PLC | 1,393,432 | $149M | 12.0% | $6.97 | — | SPONSORED ADS | 925050106 |
| — | Cidara Therapeutics, Inc. | 1,311,425 | $126M | 10.1% | $37.26 | — | Common | 171757206 |
| TERN | Terns Pharmaceuticals Inc | 6,895,746 | $51.79M | 4.2% | $11.04 | -42.2% | Common | 880881107 |
| TRVI | Trevi Therapeutics Inc | 5,094,668 | $46.62M | 3.8% | $4.23 | +77.1% | Common | 89532M101 |
| — | Avadel Pharmaceuticals PLC | 2,684,109 | $40.99M | 3.3% | $13.12 | — | ADR | G29687103 |
| COGT | Cogent Biosciences Inc | 2,789,137 | $40.05M | 3.2% | $10.52 | +12.6% | Common | 19240Q201 |
| SVA | Sinovac Biotech Ltd. | 5,903,000 | $38.19M | 3.1% | $6.47 | 0.0% | SHS | P8696W104 |
| ORIC | Oric Pharmaceuticals Inc | 3,126,604 | $37.52M | 3.0% | $7.92 | +32.8% | Common | 68622P109 |
| GERN | Geron Corp | 27,225,292 | $37.3M | 3.0% | $1.62 | -17.6% | Common | 374163103 |
| CMPX | Compass Therapeutics Inc | 9,545,466 | $33.41M | 2.7% | $3.04 | +4.1% | Common | 20454B104 |
| DYN | Dyne Therapeutics Inc | 2,614,960 | $33.08M | 2.7% | $14.50 | -21.3% | Common | 26818M108 |
| ABVX | Abivax SA - ADR | 359,305 | $30.5M | 2.5% | $84.90 | — | SPONSORED ADS | 00370M103 |
| DRUG | Bright Minds Biosciences Inc | 501,617 | $30.43M | 2.4% | $37.00 | +4.9% | Common | 10919W405 |
| — | Tourmaline Bio Inc. | 591,882 | $28.31M | 2.3% | $26.18 | — | Common | 89157D105 |
| ZBIO | Zenas Biopharma Inc | 1,183,260 | $26.27M | 2.1% | $17.98 | -9.5% | Common | 98937L105 |
| VSTM | Verastem Inc | 2,644,985 | $23.36M | 1.9% | $7.15 | +4.1% | Common | 92337C203 |
| SABS | SAB Biotherapeutics Inc | 11,420,000 | $22.95M | 1.8% | $2.26 | 0.0% | Common | 78397T202 |
| VRDN | Viridian Therapeutics Inc | 982,576 | $21.2M | 1.7% | $15.47 | +16.6% | Common | 92790C104 |
| — | Akero Therapeutics Inc | 434,689 | $20.64M | 1.7% | $47.40 | — | Common | 00973Y108 |
| ERAS | Erasca Inc | 9,273,428 | $20.22M | 1.6% | $2.00 | -20.6% | Common | 29479A108 |
| RZLT | Rezolute Inc | 2,112,432 | $19.86M | 1.6% | $1.28 | +421.6% | Common | 76200L309 |
| ACRS | Aclaris Therapeutics, Inc. | 8,888,888 | $16.89M | 1.4% | $2.49 | -29.9% | Common | 00461U105 |
| CRVS | Corvus Pharmaceuticals Holdings | 2,234,566 | $16.47M | 1.3% | $4.87 | +5.1% | Common | 221015100 |
| OLMA | Olema Pharmaceuticals Inc | 1,505,862 | $14.74M | 1.2% | $31.43 | -80.9% | Common | 68062P106 |
| DNTH | Dianthus Therapeutics Inc | 353,998 | $13.93M | 1.1% | $25.56 | 0.0% | Common | 252828108 |
| LBRX | LB Pharmaceuticals Inc | 800,000 | $12.63M | 1.0% | $15.87 | 0.0% | Common | 50180M108 |
| CAMP | CAMP4 Therapeutics Inc | 3,921,568 | $11.76M | 0.9% | $1.85 | 0.0% | Common | 13463J101 |
| — | Astria Therapeutics Inc | 1,552,685 | $11.3M | 0.9% | $10.21 | — | Common | 04635X102 |
| PEPG | Pepgen Inc | 2,325,000 | $10.74M | 0.9% | $1.61 | 0.0% | Common | 713317105 |
| DBVT | DBV Technologies SA | 1,054,506 | $10.55M | 0.8% | $9.16 | — | SPONSORED ADS | 23306J309 |
| PRAX | Praxis Precision Medicines | 198,895 | $10.54M | 0.8% | $39.72 | +22.1% | Common | 74006W207 |
| ABEO | Abeona Therapeutics, Inc. | 1,842,751 | $9.73M | 0.8% | $5.10 | +24.3% | Common | 00289Y206 |
| CTMX | Cytomx Therapeutics Inc | 2,884,615 | $9.202M | 0.7% | $1.61 | +39.7% | Common | 23284F105 |
| EPRX | Eupraxia Pharmaceuticals Inc | 1,350,000 | $7.965M | 0.6% | $5.44 | 0.0% | Common | 29842P105 |
| UNCY | Unicycive Therapeutics | 1,789,916 | $7.804M | 0.6% | $5.52 | -21.0% | Common | 90466Y202 |
| MNPR | Monopar Therapeutics Inc | 90,500 | $7.391M | 0.6% | $44.70 | 0.0% | Common | 61023L207 |
| TNGX | Tango Therapeutics Inc | 776,699 | $6.524M | 0.5% | $3.45 | +96.2% | Common | 87583X109 |
| DCTH | Delcath Systems, Inc. | 569,526 | $6.122M | 0.5% | $7.32 | +52.5% | Common | 24661P807 |
| SLN | Silence Therapeutics PLC | 1,105,454 | $5.737M | 0.5% | $19.65 | — | ADS | 82686Q101 |
| — | 89Bio Inc | 376,804 | $5.539M | 0.4% | $7.27 | — | Common | 282559103 |
| TIL | Instil Bio Inc | 292,743 | $5.228M | 0.4% | $7.23 | +250.8% | Common | 45783C200 |
| SERA | Sera Prognostics Inc | 1,650,440 | $5.05M | 0.4% | $10.38 | -72.6% | Common | 81749D107 |
| SRZN | Surrozen Inc | 260,000 | $3.35M | 0.3% | $11.62 | -9.8% | Common | 86889P208 |
| TENX | Tenax Therapeutics Inc | 208,333 | $1.585M | 0.1% | $3.62 | +68.6% | Common | 88032L605 |
| BOLT | Bolt Therapeutics Inc | 176,064 | $937K | 0.1% | $6.62 | -16.2% | Common | 097702203 |
| DTIL | Precision Biosciences Inc | 4,675 | $25,806 | 0.0% | $12.24 | -60.9% | Common | 74019P207 |